跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Larfen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Larfen
Approved
STANDARD
Larfen
Pharmathen SA
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bed790911572c2e8
Company
Pharmathen SA
Type
Standard
Approval Details
Approval Id
bed790911572c2e8
Drug Approval Philippines Name
Larfen
Product Name
Larfen
Registration Number
DR-XY43329
Brand Name
Larfen
Generic Name
Raloxifene Hydrochloride
Dosage Form
Film Coated Tablet
Dosage Strength
60 mg
Manufacturer
Pharmathen SA
Trader
Mega Lifesciences (Australia) Pty. Ltd.
Importer
Metro Drug, Inc.
Distributor
Metro Drug, Inc.
Company Detail Path
/organization/pharmathen-sa
Issuance Date
23 November 2023
Expiry Date
01 April 2029
Pharmacologic Category
Selective Estrogen Receptor Modulator
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bed790911572c2e8
Type
Standard
Back to Philippines FDA Approvals